Cantor Fitzgerald Analyst Maintains Positive Outlook on PTC Therapeutics with Adjusted Price Target
On January 27, 2024, Cantor Fitzgerald analyst Kristen Kluska expressed her positive outlook on PTC Therapeutics (NASDAQ: PTCT) by maintaining ...
Tag: PTCT
RBC Capital Analyst Lowers Price Target for PTC Therapeutics due to European Drug Rejection
On January 27, 2024, esteemed analyst Brian Abrahams from RBC Capital made a notable decision regarding PTC Therapeutics (NASDAQ: PTCT). ...
Setback for PTC Therapeutics Translarna in Europe Potential Path Forward in the US
On January 26, 2024, PTC Therapeutics was hit with a major setback in Europe. The Committee for Medicinal Products for ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
